Trials / Completed
CompletedNCT06167616
Infections and Latent Autoimmune Diabetes in Adults
Infections and Genetic Susceptibility in LADA and Type 2 Diabetes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,048 (actual)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
Infections are proposed risk factors for type 1 diabetes in children. The investigators will examine whether a diagnosis of infectious disease also confers an increased risk of latent autoimmune diabetes in adults.
Detailed description
The investigators will use data from a population-based Swedish case-control study (ESTRID) with incident cases of LADA (n=597) and matched controls (n=2386). History of infectious disease are ascertained through national and regional patient registers. The investigators will estimate adjusted odds ratios (OR) with 95% CI for ≥1 respiratory (any/upper/lower), gastrointestinal, herpetic, other or any infectious disease episode, or separately, for 1 and ≥2 infectious disease episodes, within 0-1, 1-3, 3-5 and 5-10 years before LADA diagnosis/matching. Stratified analyses will be performed based on HLA risk genotypes and GADA levels.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2019-10-31
- Completion
- 2019-10-31
- First posted
- 2023-12-12
- Last updated
- 2023-12-12
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06167616. Inclusion in this directory is not an endorsement.